1. Home
  2. XNCR vs IMOS Comparison

XNCR vs IMOS Comparison

Compare XNCR & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • IMOS
  • Stock Information
  • Founded
  • XNCR 1997
  • IMOS 1997
  • Country
  • XNCR United States
  • IMOS Taiwan
  • Employees
  • XNCR N/A
  • IMOS N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • IMOS Semiconductors
  • Sector
  • XNCR Health Care
  • IMOS Technology
  • Exchange
  • XNCR Nasdaq
  • IMOS Nasdaq
  • Market Cap
  • XNCR 579.3M
  • IMOS 551.9M
  • IPO Year
  • XNCR 2013
  • IMOS N/A
  • Fundamental
  • Price
  • XNCR $9.65
  • IMOS $19.64
  • Analyst Decision
  • XNCR Buy
  • IMOS
  • Analyst Count
  • XNCR 8
  • IMOS 0
  • Target Price
  • XNCR $29.29
  • IMOS N/A
  • AVG Volume (30 Days)
  • XNCR 968.8K
  • IMOS 19.7K
  • Earning Date
  • XNCR 08-04-2025
  • IMOS 05-13-2025
  • Dividend Yield
  • XNCR N/A
  • IMOS 3.15%
  • EPS Growth
  • XNCR N/A
  • IMOS N/A
  • EPS
  • XNCR N/A
  • IMOS 0.05
  • Revenue
  • XNCR $127,228,000.00
  • IMOS $685,506,006.00
  • Revenue This Year
  • XNCR N/A
  • IMOS N/A
  • Revenue Next Year
  • XNCR $29.35
  • IMOS $2.21
  • P/E Ratio
  • XNCR N/A
  • IMOS $20.23
  • Revenue Growth
  • XNCR N/A
  • IMOS 2.89
  • 52 Week Low
  • XNCR $7.16
  • IMOS $12.78
  • 52 Week High
  • XNCR $27.24
  • IMOS $27.80
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 59.62
  • IMOS 68.06
  • Support Level
  • XNCR $8.76
  • IMOS $18.13
  • Resistance Level
  • XNCR $9.60
  • IMOS $19.36
  • Average True Range (ATR)
  • XNCR 0.52
  • IMOS 0.65
  • MACD
  • XNCR 0.29
  • IMOS -0.01
  • Stochastic Oscillator
  • XNCR 90.87
  • IMOS 83.68

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About IMOS ChipMOS TECHNOLOGIES INC.

ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.

Share on Social Networks: